NVO Competitors & Alternatives
Compare Novo Nordisk A/S with similar stocks in the same industry
Drug Manufacturers - General
NVO
Main Stock$49.07
Tradestie Score
58
Market Cap
$262.92B
P/E Ratio
11.9
Revenue Growth
0.2%
Analyst Upside
-2.4%
Top Competitors
20 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
UNH
UNITEDHEALTH GROUP INCORPORATED (Delaware)
|
$425.19
|
$315.45B | 32.0 | 54 | Compare |
|
AZN
AstraZeneca PLC
|
$164.50
|
$261.56B | 25.8 | 41 | Compare |
|
NVS
Novartis AG
|
$150.36
|
$254.99B | 22.1 | 55 | Compare |
|
MRK
Merck & Co., Inc.
|
$120.78
|
$225.13B | 34.8 | 57 | Compare |
|
AMGN
Amgen Inc
|
$355.25
|
$160.70B | 25.3 | 56 | Compare |
|
PFE
Pfizer Inc.
|
$24.25
|
$154.70B | 18.5 | 61 | Compare |
|
GILD
Gilead Sciences Inc
|
$130.04
|
$137.92B | 17.7 | 65 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$43.18
|
$121.27B | 19.3 | 62 | Compare |
|
BMY
Bristol-Myers Squibb Co.
|
$56.95
|
$96.54B | 16.1 | 64 | Compare |
|
GSK
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
|
$51.25
|
$91.59B | 14.1 | 51 | Compare |
More NVO Analysis
Data updated: Jul 14, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
20 stocks in this industry